3.2.3 - Post Exposure Follow-up

1. Following an exposure incident, a confidential examination and follow-up shall be made available to the WM to address such infectious diseases as HBV, HCV, and HIV. This shall include confidential post-exposure prophylaxis and counseling following the current CDC protocol.
2. The healthcare professional providing treatment must forward a written opinion (as outlined in the OSHA regulation) to the WM and the appropriate OU Health Employee Health clinic, OUHSC/OU Tulsa Student Health clinic, or for satellite locations, the COD Director of Compliance, and maintain a copy on file.
3. Additional information regarding the OUHSC/OU-Tulsa policies and procedures for Hepatitis B vaccination and post-exposure follow-up may be found in the OUHSC/OU-Tulsa Infectious Diseases Policy.
4. If the source patient’s HIV test is positive, prophylactic medications are available in the inpatient pharmacy.
5. If the source patient's results are positive or if the source patient is unknown, the WM should undergo periodic laboratory testing.
   1. Initial baseline test
   2. Six weeks
   3. Three months
   4. Six months

• OU Health Employee Health or OUHSC/OU Tulsa Student Health will manage the post-exposure evaluation and ensure the WM receives necessary care throughout the process.

6. If the source patient’s HIV test is negative, there is no further testing or follow-up needed.

Procedures for evaluating circumstances surrounding exposure incidents:

1. Once the incident report is received by the COD Office of Compliance, a review of the circumstances of all exposure incidents will be completed to determine the following:
   1. Engineering controls were in use at the time.
   2. A description of the device being used (including type and brand).
   3. PPE or clothing that was used at the time of the exposure incident (e.g., gloves, face shields, safety glasses, etc.).
   4. Location of the incident.
   5. The procedure being performed when the incident occurred.
   6. WM’s training.
2. The COD Office of Compliance will record the percutaneous injuries from contaminated sharps in the sharps injury log.
3. If revisions to the ECP are necessary, the Director of Compliance will ensure proper changes are made such as safer devices, adding job functions to the exposure determination section, procedural changes, etc.

To ensure that workforce member's concerns regarding needle sticks and other sharp injuries are addressed; the EHSO asks that they complete a Safer Needle Device Questionnaire annually.